KP Bioscience

R&D

We become the most trusted partner of our customers and make a better life for patients

KP-TR

  • Pipeline

    KP-TR

  • Program Target

    VEGF, TGF-beta

  • Disease Indication

    Neovascular glaucoma

KP-TR mechanism

Target indication Drug discovery Drug optimization Pre-clinical Phase 1 Phase 2 Phase 3
Neovascular glaucoma